News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Friday, January 10, 2025
      News & Perspective Drugs & Diseases CME & Education Video Decision Point

      From Medscape Gastroenterology

      Coverage from the

      The Liver Meeting 2024: American Association for the Study of Liver Diseases (AASLD)

      November 15 - 19, 2024; San Diego, California

      November 15 - 19, 2024 San Diego, California

      Conference News

      Medscape Gastroenterology© 

      Popular News From AASLD 2023

      • Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers A single daily low dose of aspirin significantly reduced hepatic fat fraction and liver transaminase levels in a randomized trial in patients with metabolic-associated steatotic liver disease.
        Medscape Medical News, Nov 16, 2023
      • Weight-Loss Drugs Improve Liver Measures Too Weight-Loss Drugs Improve Liver Measures Too For patients who experienced rapid and significant weight reduction while taking an SGLT-2 inhibitor or a GLP-1 agonist, ALT values normalized, suggesting a beneficial effect on liver health.
        Medscape Medical News, Nov 13, 2023
      • MASLD, MASH Projected to Grow by 23% in the US Through 2050 MASLD, MASH Projected to Grow by 23% in the US Through 2050 A mathematical model forecasts a steady increase in liver disease burden, including a near doubling of liver cancers and a more than twofold increase in liver transplants.
        Medscape Medical News, Nov 08, 2023

      Previous Coverage

      Related Resources

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Manage Preferences Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      Editions
      English Deutsch Español Français Português
      All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.